5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Dishman Carbogen Amcis Ltd.

•
dishmangroup.comBSE: 540701NSE: DCAL
Market Cap₹ 2,623 Cr.
Current Price
High / Low₹ 322 / 128
Stock P/E162.3
Book Value₹ 422
Price to Book0.59
Dividend Yield0.00 %
ROCE2.3 %
ROE0.1 %
Face Value₹ 2

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2022 • CRAMS: 77.0% • Vitamin-D, Bulk Drugs, Quats, Speciality Chemicals and traded goods: 23.0%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company generates healthy free cash flow
  • Company maintains a comfortable, low leverage position

CONS

  • A large part of profit comes from other income (263.5% of PBT)
  • Recent results are weak - TTM profit is down 87.8% versus prior year
  • Receivables are growing faster than sales - a possible quality concern
  • Company has a low return on capital employed of 0.9%
  • Company has a low return on equity of -1.1% over last 3 years
  • Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -5.67x)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.DCAL167.30162.312622.980.00-57.88-347.24677.64-4.292.318.87
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
723587651655524789682716708653720851678
602526610592495642542564567504607688745
Operating Profit12261416329147140153141149113163-68
OPM %16.85%10.37%6.31%9.57%5.53%18.65%20.54%21.32%19.87%22.81%15.71%19.14%-9.99%
7564-448-422871520
Interest28273331323749424342464337
Depreciation70758085717272798184848991
Profit before Tax29-36-66-49-784227283931-1046-51
Tax %42.35%-12.80%10.05%-42.11%-0.01%21.44%82.88%-55.56%39.46%-113.72%-24.23%52.87%-13.00%
Net Profit0000-78335432365-1322-58
1.08-2.61-3.80-4.46-4.952.110.302.751.494.16-0.831.39-3.69

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
1,7141,6952,0592,0441,9122,1412,4132,6162,7122,901
1,2601,2571,5071,5461,6381,8152,0812,3522,2722,544
Operating Profit453438552498274326332264440357
OPM %26.45%25.85%26.81%24.35%14.34%15.21%13.77%10.09%16.22%12.31%
265354441634-20453350
Interest49495762485786120159169
Depreciation214211240283308308281311294348
Profit before Tax216231309197-65-4-55-1221915
Tax %32.70%33.03%31.89%19.62%-153.93%523.76%45.41%-25.51%83.22%-7.66%
Net Profit145155210159-16518-30-153316
EPS9.019.5813.0310.10-10.531.15-1.90-9.790.21—
Dividend Payout %—0.00%1.53%0.00%0.00%0.00%0.00%0.00%0.00%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
6%
3 Years:
8%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
-54%
3 Years:
-44%

STOCK PRICE CAGR

10 Years:
—
5 Years:
-4%
3 Years:
3%
1 Year:
-38%

RETURN ON EQUITY

10 Years:
—
5 Years:
-1%
3 Years:
-1%
Last Year:
0%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

No bonus data found

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital03232313131313131
45,0755,3475,6845,6675,5185,7785,5965,800
8509188831,1651,4171,7562,2182,6012,534
Trade Payables86186195284169193220244231
5,6359578641,0291,0711,1361,1921,0981,391
Total Liabilities6,5747,1697,3218,1938,3568,6349,4399,5719,986
4,8475,0615,0925,6735,6935,7686,1836,7207,051
Capital Work in Progress122119143202425755996501252
4019616719117232424910297
427485549581516645804883900
0000000484665
Cash & Bank876996161308172189413507
1,0521,2401,2731,3861,2429701,018467514
Total Assets6,5747,1697,3218,1938,3568,6349,4399,5719,986

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
418260412660564411300379375
Cash from Investing-142-297-169-442-380-619-494-230-192
Cash from Financing-13778-102-98-11130250-22-102
2371146122-1332212881

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
59.3259.3259.3259.3259.3259.3259.3259.3259.32
8.058.188.759.499.948.077.667.456.86
1.471.221.411.251.261.361.261.622.05
Government0.000.000.000.000.000.000.000.000.00
31.1731.2930.5229.9429.4831.2431.7631.6131.76

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-12
General Updates

2026-09-12 - Dishman Carbogen Amcis Limited has informed the Exchange about General Updates

2026-09-07
Copy of Newspaper Publication

2026-09-07 - Dishman Carbogen Amcis Limited has informed the Exchange about Copy of Newspaper Publication regarding intimation of 19th AGM and E-Voting Instructions.

2026-09-05
Shareholders meeting

2026-09-05 - Dishman Carbogen Amcis Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026

2026-09-02
Copy of Newspaper Publication

2026-09-02 - Dishman Carbogen Amcis Limited has informed the Exchange about Copy of Newspaper Publication for intimation regarding 19th AGM to be held through Video Conferencing or Other Audio Visual Means.

2026-08-31
Updates

2026-08-31 - Dishman Carbogen Amcis Limited has informed the Exchange regarding 'Intimation regarding date of 19th Annual General Meeting'.

2026-08-29
Cessation

2026-08-29 - Dishman Carbogen Amcis Limited has informed the Exchange regarding Cessation of Mr Deepak Ram Chandra Mittal as Other of the company w.e.f. August 27, 2026.

2026-08-21
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-21 - Dishman Carbogen Amcis Limited has informed the Exchange about Transcript

2026-08-17
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-17 - Dishman Carbogen Amcis Limited has informed the Exchange about Link of Recording

2026-08-17
Allotment of Securities

2026-08-17 - Dishman Carbogen Amcis Limited has informed the Exchange regarding allotment of 7500 securities pursuant to Non Convertible Securities at its meeting held on August 17, 2026

News

Recent coverage and analyst commentary for DCAL

Loading news…

🤖

AI Stock Analyst

Dishman Carbogen Amcis Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login